Home/ Stocks/ SMMT

Summit Therapeutics Inc. Common Stock

SMMT XNAS

$16.33 +2.11 (+14.87%) ▲ 15-min delayed

Open

$14.79

High

$16.36

Low

$14.66

Volume

5.80M

Market Cap

$13.06B

About Summit Therapeutics Inc. Common Stock

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 265 Website →

Related Market News

No specific coverage for SMMT yet. Check out our latest market news or earnings calendar.

Get SMMT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Summit Therapeutics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.